CIM
GILD icon

Chapman Investment Management’s Gilead Sciences GILD Stock Holding History

Chapman Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,000
Closed -$419K – 52
2021
Q3 		$419K Hold
6,000
– – 0.22% 40
2021
Q2 		$413K Hold
6,000
– – 0.23% 39
2021
Q1 		$388K Hold
6,000
– – 0.24% 36
2020
Q4 		$350K Hold
6,000
– – 0.23% 35
2020
Q3 		$379K Hold
6,000
– – 0.28% 36
2020
Q2 		$462K Buy
+6,000
New +$460K 0.38% 37

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Chapman Investment Management's GILD Position: Q4 2021 in Review

Chapman Investment Management sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 6,000 shares — an estimated $419K sold.

Chapman Investment Management first reported a position in GILD in Q2 2020 and held it in 6 quarters. The position peaked at $462K in Q2 2020. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Chapman Investment Management reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
  • Chapman Investment Management sold 6,000 Gilead Sciences shares in Q4 2021, an estimated $419K.
  • Chapman Investment Management first reported a position in Gilead Sciences in Q2 2020 and held it in 6 quarters.
  • Chapman Investment Management's Gilead Sciences position peaked at $462K in Q2 2020.
  • 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Chapman Investment Management's 13F filing for Q4 2021, filed 20 Jan 2022.